Patient & Survivor Care
Conference Coverage
ICIs improve pCR rates in early ER+/HER2– breast cancer
Nivolumab and pembrolizumab boosted pathologic complete response rates when added to neoadjuvant and adjuvant therapy in patients with high-risk...
Conference Coverage
Observation, not radiotherapy, after radical prostatectomy
The investigators observed no benefit to adjuvant radiotherapy after radical prostatectomy in patients with prostate cancer in the phase 3...
Conference Coverage
No benefit to adding ICI to chemo in triple-negative breast cancer: study
There were no differences in 5-year event-free survival among patients with TNBC who received neoadjuvant chemotherapy with or without...
Conference Coverage
Remote symptom monitoring in advanced cancer improves quality of life
Building on prior studies, a new trial shows that digital symptom monitoring during cancer treatment detects symptoms early, improves quality of...
Conference Coverage
Fasting during breast cancer chemo improves quality of life
Short-term fasting around the time of chemotherapy is a promising supportive therapy during breast cancer chemotherapy that may enhance quality of...
Conference Coverage
Does first-line pembrolizumab add-on improve PFS in high-risk cervical cancer?
An FDA decision is expected in January on pembrolizumab with concurrent chemoradiotherapy for the first-line treatment of locally advanced...
Conference Coverage
Adjuvant abemaciclib-ET combo shows long-term benefit in high-risk early breast cancer
Invasive disease–free and distant recurrence–free survival were better with the CDK4/6 inhibitor plus endocrine therapy than endocrine therapy...
From the Journals
Breast reconstruction post mastectomy: What matters most to women?
“This study provides information on how women value different aspects of their care when making decisions for breast reconstruction.”
Conference Coverage
Head, neck cancer radiotherapy regimen saves time when resources limited
A randomized controlled trial conducted in low- to middle-income countries showed that 11.5 days could be safely shaved off a conventional...
From the Journals
Does surgery improve survival in metastatic breast cancer?
“The analysis revealed no overall survival benefit for patients who underwent surgical excision of their primary breast tumor.”
Conference Coverage
‘Reassuring’ follow-up validates radiation strategy for early breast cancer
At 10 years, partial-breast/reduced-dose therapy are still noninferior to whole-breast approach.